First Page | Document Content | |
---|---|---|
Date: 2018-02-11 19:58:19 | 19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple ScleroAdd to Reading ListSource URL: www.antisense.com.auDownload Document from Source WebsiteFile Size: 46,58 KBShare Document on Facebook |